COVID-19 Medicines Optimisation: Specialty Guidance

Summary of COVID-19 medicines guidance: Haematological disorders

26 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and haematological disorders. Our advice…

Summary of COVID-19 medicines guidance: Obstetrics and gynaecology

26 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and obstetrics and gynaecology. Our…

Summary of COVID-19 medicines guidance: Palliative and End of Life Care

21 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and palliative and end of…

Summary of COVID-19 medicines guidance: Stroke

21 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and stroke. Our advice is…

Summary of COVID-19 medicines guidance: Allergy and immunology

20 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and allergy and immunology conditions.…

Summary of COVID-19 medicines guidance: Cardiovascular system disorders

20 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and cardiovascular system disorders. Our…

Summary of COVID-19 medicines guidance: Mental health and illness

20 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and mental health and illness.…

Summary of COVID-19 medicines guidance: Skin disorders

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and skin disorders. Our advice…

Summary of COVID-19 medicines guidance: Later life

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and later life disorders. Our…

Summary of COVID-19 medicines guidance: Diabetes

12 January 2021This page summarises and signposts to medicine related guidance we’re aware of from professional and government bodies relating to coronavirus and diabetes. Our advice is…